PTC Therapeutics Inc. buy Wells Fargo & Company
Start price
27.05.25
/
50%
€41.80
Target price
27.05.26
€64.95
Performance (%)
-2.87%
Price
15.08.25
€41.00
Summary
This prediction is currently active. With a performance of -2.87%, the BUY prediction for PTC Therapeutics Inc. by Wells_Fargo___Compan is down slightly. This prediction currently runs until 27.05.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | -3.302% | -3.302% |
| iShares Core DAX® | 0.648% | 1.259% |
| iShares Nasdaq 100 | -0.034% | 2.797% |
| iShares Nikkei 225® | 2.445% | 9.854% |
| iShares S&P 500 | 0.492% | 2.570% |
Comments by Wells_Fargo___Compan for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Wells Fargo & Company from $68.00 to $74.00. They now have an "overweight" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€39.00
08.08.25
08.08.25
€67.74
08.08.26
08.08.26
7.18%
15.08.25
15.08.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€43.60
29.07.25
29.07.25
€67.26
29.07.26
29.07.26
-4.13%
15.08.25
15.08.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€45.40
26.11.24
26.11.24
€64.72
26.11.25
26.11.25
-7.93%
15.08.25
15.08.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.20
08.12.23
08.12.23
€34.41
08.12.24
08.12.24
78.51%
09.12.24
09.12.24